Sirturo 100 MG (as bedaquiline fumarate 120.9 MG) Oral Tablet
- RxCUI
- 1364515
- RxNorm name
- Sirturo 100 MG (as bedaquiline fumarate 120.9 MG) Oral Tablet
- Display name
- Sirturo 100 MG (as bedaquiline fumarate 120.9 MG) Oral Tablet
- Full name
- Sirturo 100 MG (as bedaquiline fumarate 120.9 MG) Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:48
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SIRTURO | BEDAQUILINE FUMARATE | Janssen Products, LP | 1534c9ae-4948-4cf4-9f66-222a99db6d0e | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | 1364515 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1534c9ae-4948-4cf4-9f66-222a99db6d0e | Sirturo 100 MG Oral Tablet [PSN] · bedaquiline 100 MG Oral Tablet [Sirturo] [SBD] · Sirturo 100 MG (as bedaquiline fumarate 120.9 MG) Oral Tablet [SY] · Sirturo 100 MG Oral Tablet [SY] | 4 | 33 | These highlights do not include all the information needed to use SIRTURO safely and effectively. See full prescribing information for SIRTURO. SIRTURO ® (bedaquiline) tablets, for oral use Initial U.S. Approval: 2012 | 20251017 |